Domiciliation des cellules dendritiques = Migration of dendritic cellsROBERT, Caroline.Hématologie (Montrouge). 2004, Vol 10, Num 4, pp 265-273, issn 1264-7527, 9 p.Article

Leukocyte trafficking in the skinROBERT, Caroline.EJD. European journal of dermatology. 2002, Vol 12, Num 6, pp V-VI, issn 1167-1122Conference Paper

Traitement du mélanome: le temps des combinaisons thérapeutiques = Treatment of melanoma: time for therapeutic combinationsROBERT, Caroline.La Revue du praticien (Paris). 2014, Vol 64, Num 2, issn 0035-2640, S3-S4, SUPArticle

Anticorps anti-CTLA-4: Une avancée thérapeutique majeure dans le traitement du mélanome métastatique = Anti-CTLA-4 monoclonal antibody: a major step in the treatment of metastatic melanomaROBERT, Caroline; MATEUS, Christine.MS. Médecine sciences. 2011, Vol 27, Num 10, pp 850-858, issn 0767-0974, 9 p.Article

Tumeurs cutanées, épithéliales et mélaniques = Epithelial and melanic skin tumoursMATEUS, Christine; ROBERT, Caroline.La Revue du praticien (Paris). 2007, Vol 57, Num 18, pp 2067-2079, issn 0035-2640, 13 p.Article

Des avancées thérapeutiques majeures dans le traitement du mélanome métastatique = Major therapeutic advances in the treatment of metastatic melanomaMATEUS, Christine; ROBERT, Caroline.Bulletin du cancer. 2012, Vol 99, Num 6, pp 619-625, issn 0007-4551, 7 p.Article

New drugs in melanoma: It's a whole new worldEGGERMONT, Alexander M. M; ROBERT, Caroline.European journal of cancer (1990). 2011, Vol 47, Num 14, pp 2150-2157, issn 0959-8049, 8 p.Article

Effets secondaires cutanés des molécules anti-angiogéniques = Cutaneous side effects of antiangiogenic agentsROBERT, Caroline.Bulletin du cancer. 2007, Vol 94, Num JUIL, issn 0007-4551, S260-S264, NSArticle

Cutaneous melanomaEGGERMONT, Alexander M. M; SPATZ, Alan; ROBERT, Caroline et al.Lancet (British edition). 2014, Vol 383, Num 9919, pp 816-827, issn 0140-6736, 12 p.Article

Détection de la maladie micrométastatique résiduelle du mélanome: le rôle du ganglion sentinelle : Curage ganglionnaire = Detection of residual microscopic disease in melanoma: interest of the sentinel lymph node procedure ? : Lymph node dissectionMATEUS, Christine; THOMAS, Marina; ROBERT, Caroline et al.Bulletin du cancer. 2014, Vol 101, Num 4, pp 354-357, issn 0007-4551, 4 p.Article

L'annonce du diagnostic de mélanome : CANCERS CUTANÉS = How to announce the diagnosis for melanoma? : SKIN CANCERCHARLES, Cécile; ROUBY, Pascal; ROBERT, Caroline et al.La Revue du praticien (Paris). 2014, Vol 64, Num 1, pp 55-60, issn 0035-2640, 6 p.Article

CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma PatientsOTT, Patrick A; HODI, F. Stephen; ROBERT, Caroline et al.Clinical cancer research (Print). 2013, Vol 19, Num 19, pp 5300-5309, issn 1078-0432, 10 p.Article

Hand-Foot Syndrome (Hand-Foot Skin Reaction, Palmar-Plantar Erythrodysesthesia): Focus on Sorafenib and SunitinibLIPWORTH, Adam D; ROBERT, Caroline; ZHU, Andrew X et al.Oncology. 2009, Vol 77, Num 5, pp 257-271, issn 0030-2414, 15 p.Article

L'immunothérapie dans le mélanome = Immunotherapies and melanomaROUTIER, Emilie; ROBERT, Caroline; MATEUS, Christina et al.Bulletin du cancer. 2014, Vol 101, issn 0007-4551, S13-S24, SUP2Article

Gestion des effets secondaires des thérapies ciblées dans le cancer du rein: thérapies ciblées et effets secondaires dermatologiques = Management of side effects of targeted therapies in renal cancer: cutaneous side effectsROBERT, Caroline; GIMEL, Pierre.Bulletin du cancer. 2011, Vol 98, issn 0007-4551, S35-S46, SUP3Article

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trialROBERT, Caroline; RIBAS, Antoni; PATNAIK, Amita et al.Lancet (British edition). 2014, Vol 384, Num 9948, pp 1109-1117, issn 0140-6736, 9 p.Article

Prise en charge du mélanome : CANCERS CUTANÉS = Management of patients with melanoma : SKIN CANCERROBERT, Caroline; CAVALCANTI, Andrea; KOLB, Frédéric et al.La Revue du praticien (Paris). 2014, Vol 64, Num 1, pp 75-80, issn 0035-2640, 6 p.Article

Impact des toxicités cutanées associées aux thérapies ciblées sur la qualité de vie. Résultats d'une étude pilote longitudinale = Impact of cutaneous toxicities associated with targeted therapies on quality of life. Results of a longitudinal exploratory studyCHARLES, Cécile; SULTAN, Serge; BUNGENER, Catherine et al.Bulletin du cancer. 2013, Vol 100, Num 3, pp 213-222, issn 0007-4551, 10 p.Article

Phase II, Open-Label, Randomized Trial of the MEK1/2 Inhibitor Selumetinib as Monotherapy versus Temozolomide in Patients with Advanced MelanomaKIRKWOOD, John M; BASTHOLT, Lars; DUMMER, Reinhard et al.Clinical cancer research (Print). 2012, Vol 18, Num 2, pp 555-567, issn 1078-0432, 13 p.Article

Targeted Therapies for Renal Cell Carcinoma: Review of Adverse Event Management StrategiesEISEN, Tim; STERNBERG, Cora N; ROBERT, Caroline et al.Journal of the National Cancer Institute. 2012, Vol 104, Num 2, pp 93-113, issn 0027-8874, 21 p.Article

Prognosis in Patients With Sentinel Node―Positive Melanoma Is Accurately Defined by the Combined Rotterdam Tumor Load and Dewar Topography CriteriaVAN DER PLOEG, Augustinus P. T; VAN AKKOOI, Alexander C. J; VAN DEN HOUT, Mari F. C. M et al.Journal of clinical oncology. 2011, Vol 29, Num 16, pp 2206-2214, issn 0732-183X, 9 p.Article

CTLA-4 Blockade Confers Lymphocyte Resistance to Regulatory T-Cells in Advanced Melanoma : Surrogate Marker of Efficacy of Tremelimumab?MONARD, Cédric; GHIRINGHELLI, Francois; ROUX, Stephan et al.Clinical cancer research (Print). 2008, Vol 14, Num 16, pp 5242-5249, issn 1078-0432, 8 p.Article

Drug of the year: Programmed Death-1 receptor/Programmed Death-1 Ligand-1 receptor monoclonal antibodiesROBERT, Caroline; SORIA, Jean-Charles; EGGERMONT, Alexander M. M et al.European journal of cancer (1990). 2013, Vol 49, Num 14, pp 2968-2971, issn 0959-8049, 4 p.Article

Prognostic Factors of Paraneoplastic PemphigusLEGER, Sandy; PICARD, Damien; D'INCAN, Michel et al.Archives of dermatology (1960). 2012, Vol 148, Num 10, pp 1165-1172, issn 0003-987X, 8 p.Article

Prospective Study of the Cutaneous Adverse Effects of Sorafenib, a Novel Multikinase InhibitorAUTIER, Julien; ESCUDIER, Bernard; WECHSLER, Janine et al.Archives of dermatology (1960). 2008, Vol 144, Num 7, pp 886-892, issn 0003-987X, 7 p.Article